Navigation Links
Kidney Transplant Recipients Tardy In Taking Vital Medications

Waiting for a kidney transplant is agonizing, but taking the medications for preventing a transplant rejection more so. But it has emerged that more than 25 out of 100 transplant patients do not take their medications.//

Now, a nursing researcher at the University of Missouri-Columbia is studying the pattern of missing does and is trying to work on intervention methods. Cindy Russell, assistant professor in the MU Sinclair School of Nursing is using the Medication Event Monitoring System (MEMS) to follow such patients. The MEMS has a microchip in the cap to record the date and time the cap is removed to take medicine, thus keeping track of when it is taken. “With this information, we hope to find characteristics that could predict potential problems and develop intervention methods that would help keep kidney transplant patients as healthy as possible and extend the life of their new kidneys and their lives overall,” Russell said. Initial results point to many patients being regular, with few being tardy, while the rest regularly miss doses. “We expected the amount of time that had passed since the transplant to make a difference in medication adherence, but we didn’t see that,” Russell sad.
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Kidney Stones - Interesting New Research implicates bacteria as its cause
3. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
4. New Dietary Approach To Manage Kidney Stones
5. Kidney cancer on the rise
6. Kidney function can be affected by lead exposure
7. Kidney Failure after Non-Kidney Transplants
8. Kidney Patients Risk Heart Attacks
9. Kidney Patients Risk Heart Attacks
10. Urine Test for Kidney Cancer
11. New Hope for Kidney Failure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the ... of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... 28, 2016 Dr. Vivek Ahuja ... and Ste phen Schmidt ... leading provider of cloud-based software solutions for life sciences, today announced ... bring a wealth of insight to a growing business.  This will ... George Phillips joined ArisGlobal in the position of ...
Breaking Medicine Technology: